Head and neck cancer trials in Brazil
10 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleJNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
- Where
- Barretos, Belo Horizonte, Fortaleza, Ipatinga, Jaú, Londrina, Porto Alegre, Rio de Janeiro, Salvador, São José do Rio Preto, São Paulo, Vitória
- Age
- 60 years and over
- People
- 500 worldwide
- Run by
- Johnson & Johnson Enterprise Innovation Inc.
See details and how to joinNCT04892173 · EU 2024-520386-31-00 - Phase 3Taking peopleA Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Where
- Jaú, Natal, Porto Alegre, São José do Rio Preto, São Paulo, Vitória
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07276399 · EU 2025-521917-24-00 - Phase 2/3Taking peopleFORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Where
- Barretos, Belém, Curitiba, Fortaleza, Ijuí, Jaú, Natal, Passo Fundo, Porto Alegre, Rio de Janeiro, Santa Cecília, Santa Cruz do Sul, Santa Lúcia, São Caetano do Sul, São José do Rio Preto, São Paulo
- Age
- 18 years and over
- People
- 650 worldwide
- Run by
- Bicara Therapeutics
See details and how to joinNCT06788990 · EU 2024-519654-37-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Barretos, Florianópolis, Jaú, Porto Alegre
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 3Taking peopleProphylactic Antibiotic Duration in Head and Neck Cancer Surgery (PROTECT-HN Trial)
- Where
- São Paulo
- Age
- 18 years and over
- People
- 80
- Run by
- AC Camargo Cancer Center
See details and how to joinNCT07851857 - Phase 3Taking peopleA Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- Where
- Barretos, Florianópolis, Fortaleza, Ijuí, Ipatinga, Londrina, Natal, Porto Alegre, Ribeirão Preto, Rio de Janeiro, São Paulo, Teresina
- Age
- 18 years to 130 years
- People
- 1,145 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06129864 - Phase 2Taking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Ijuí, Londrina, Natal, Porto Alegre, Santo André, São Caetano do Sul, Vitória
- Age
- 18 years to 64 years
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - No phaseTaking peopleImpact of HMB Supplementation on Inflammation and Outcomes in Head and Neck Cancer
- Where
- Belo Horizonte
- Age
- 18 years and over
- People
- 66
- Run by
- Federal University of Minas Gerais
See details and how to joinNCT07675421 - Phase 3Taking peopleA Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- Where
- Barretos, Belo Horizonte, Florianópolis, Ijuí, Jaú, Joinville, Natal, Porto Alegre, Salvador, São José do Rio Preto, São Paulo, Vitória
- Age
- 18 years and over
- People
- 864 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06256588 · EU 2023-508613-17-00 - Phase 2Enrolling by invitationOral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy
- Where
- Rio de Janeiro
- Age
- 18 years and over
- People
- 84
- Run by
- Instituto Oncoclinicas
See details and how to joinNCT07363031